Answers are grounded in this paper and cite their sources.
PURPOSE: To establish a CT number-to-electron/mass density (CT-ED/MD) calibration curve for the HyperSight cone-beam CT (CBCT) system on the Ethos platform, perform end-to-end dosimetric validation, and evaluate whether a single curve applies across kV imaging energies. METHODS: An electron density phantom (CIRS 062 M) was scanned at 125 and 140 kV and reconstructed using iterative CBCT (iCBCT) Acuros and metal artifact reduction (MAR) algorithms. A 125-kV curve was generated from the averaged Acuros/MAR HU values. Ten intensity-modulated radiotherapy/volumetric-modulated arc therapy plans spanning five disease sites (glioma, brain stereotactic radiation therapy (SRT), mediastinal tumor, lung stereotactic body radiation therapy (SBRT), and prostate cancer) were created on simulation CT for anthropomorphic head, thorax, and pelvis phantoms and recalculated on HyperSight images using the single curve. Validation included ionization-chamber point-dose measurement, 3D gamma analysis, dose-volume histogram comparison, and equivalence testing. RESULTS: The averaged 125-kV curve agreed closely with the Philips 120-kV simulation CT curve. All 50 point-dose comparisons fell within ± 2% (82% within ± 1%), with mean differences of -0.24% to + 0.03% across disease sites, kV energies, and reconstruction algorithms. Mean body gamma pass rates were 99.79% (1%/1 mm) and 99.97% (2%/2 mm); mean target pass rates were 98.04% and 99.79%. Target mean-dose differences versus simulation CT averaged 0.11% (maximum 0.46%), and equivalence was confirmed within ± 2%. CONCLUSIONS: A single, locally generated 125-kV CT-ED/MD curve based on averaged Acuros/MAR HU values enables clinically acceptable HyperSight-based dose calculation, supporting a simplified single-curve commissioning workflow for online adaptive radiotherapy.
No takes yet. Share an insight, caveat, or question.
Meng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: